Search Within

Yanming Zhang

  1. "Gynecologic Medicine Service"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (8)
  2. Department of Pathology and Laboratory Medicine (8)
  3. Gynecologic Medicine Service (8)
  4. Solid Tumor Oncology Division (8)
  5. GDMT, Medicine (6)
  6. GDMT, Pathology and Laboratory Medicine (6)

More Groups

People
  1. Britta Weigelt (5)
  2. Dara Ross (5)
  3. Michael Herman Chui (5)
  4. Vicky Makker (4)
  5. Ahmet Zehir (3)
  6. Alexander Drilon (3)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (2)
  4. 2021 (2)
  5. 2020 (2)
Publications
  1. Modern Pathology (2)
  2. American Journal of Surgical Pathology (1)
  3. Annals of Oncology (1)
  4. Cancer Research (1)
  5. JCO Precision Oncology (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (2)
  2. Nature Research (2)
  3. American Association for Cancer Research (1)
  4. Lippincott Williams & Wilkins (1)
  5. Oxford University Press (1)
  6. Wiley Blackwell (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Decreased HER2 expression in endometrial cancer following anti-HER2 therapy
    Journal Article

    Chui, M. H.; Brown, D. N.; Da Cruz Paula, A.; da Silva, E. M.; Momeni-Boroujeni, A.; Reis-Filho, J. S.; Zhang, Y.; Makker, V.; Ellenson, L. H.; Weigelt, B.
    Journal of Pathology (2024)

    Fulltext@MSK | Save
  • HER2 genetic intratumor heterogeneity is associated with resistance to trastuzumab and trastuzumab emtansine therapy in recurrent high-grade endometrial cancer
    Journal Article

    Shen, S.; Ma, W.; Brown, D.; Da Cruz Paula, A.; Zhou, Q.; Iaosonos, A.; Tessier-Cloutier, B.; Ross, D. S.; Troso-Sandoval, T.; Reis-Filho, J. S.; more...
    Modern Pathology (2023)

    Fulltext@MSK | Save
  • Clinicopathologic and molecular features associated with response to anti-HER2 therapy in endometrial cancer
    Meeting Abstract

    Shen, S.; Ma, W.; Zhou, Q.; Iasonos, A.; Zhang, Y.; Ross, D. S.; Makker, V.; Chui, M. H.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Histopathologic features and molecular genetic landscape of HER2-amplified endometrial carcinomas
    Journal Article

    Ross, D. S.; Devereaux, K. A.; Jin, C.; Lin, D. Y. T.; Zhang, Y.; Marra, A.; Makker, V.; Weigelt, B.; Ellenson, L. H.; Chui, M. H.
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • Spectrum of BRAF mutations and gene rearrangements in ovarian serous carcinoma
    Journal Article

    Chui, M. H.; Chang, J. C.; Zhang, Y.; Zehir, A.; Schram, A. M.; Konner, J.; Drilon, A. E.; da Cruz Paula, A.; Weigelt, B.; Grisham, R. N.
    JCO Precision Oncology (2021)

    Fulltext@MSK | Save
  • Genomic profiling aids classification of diagnostically challenging uterine mesenchymal tumors with myomelanocytic differentiation
    Journal Article

    Selenica, P.; Conlon, N.; Gonzalez, C.; Frosina, D.; Jungbluth, A. A.; Beets-Tan, R. G. H.; Rao, M. K.; Zhang, Y.; Benayed, R.; Ladanyi, M.; more...
    American Journal of Surgical Pathology (2021)

    Fulltext@MSK | Save
  • Kinase fusions drive endocrine resistance in estrogen receptor-positive breast cancer
    Meeting Abstract

    Liu, B.; Ross, D. S.; Schram, A. M.; Razavi, P.; Lagana, S. M.; Zhang, Y.; Scaltriti, M.; Bromberg, J. F.; Ladanyi, M.; Hyman, D. M.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Enrichment of kinase fusions in ESR1 wild-type, metastatic breast cancer revealed by a systematic analysis of 4854 patients
    Journal Article

    Ross, D. S.; Liu, B.; Schram, A. M.; Razavi, P.; Lagana, S. M.; Zhang, Y.; Scaltriti, M.; Bromberg, J. F.; Ladanyi, M.; Hyman, D. M.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save